Names of Basal Insulin
Basal insulin options include NPH, glargine, detemir, and degludec, which are designed to provide a relatively constant level of insulin to control blood glucose between meals and overnight. 1
Types of Basal Insulin
Human Basal Insulin
- NPH (Neutral Protamine Hagedorn) - an intermediate-acting human insulin that may be administered once or twice daily 1
Long-Acting Insulin Analogs
Insulin glargine (U-100 and U-300 formulations)
Insulin detemir
Insulin degludec
Characteristics of Basal Insulins
Mechanism of Action
- Basal insulins are designed to cover the body's basal metabolic insulin requirement by primarily regulating hepatic glucose production 1
- They provide relatively constant insulin levels without pronounced peaks, unlike prandial (mealtime) insulins 2
Pharmacodynamic Differences
- NPH insulin has a more pronounced peak and shorter duration compared to long-acting analogs 1
- Long-acting analogs (glargine, detemir, degludec) have flatter profiles with less within-patient variability 6, 7
- Insulin degludec forms multi-hexamers when injected subcutaneously, resulting in an ultra-long duration of action 5
Clinical Considerations
- Long-acting insulin analogs generally have a lower risk of nocturnal hypoglycemia compared to NPH insulin 1, 2
- Insulin detemir is associated with less weight gain compared to insulin glargine, but may require higher doses and twice-daily administration in some patients 4
- Insulin degludec offers the potential for flexible dosing due to its ultra-long duration of action 6
Dosing Considerations
- Basal insulin is typically initiated at 10 units or 0.1-0.2 units/kg/day, depending on the degree of hyperglycemia 1
- Dose adjustments are made based on fasting blood glucose levels 1
- Some patients may require twice-daily dosing with certain basal insulins (particularly NPH and sometimes detemir) 1, 4
Practical Considerations
- Basal insulin is often the first insulin added to oral medications when initiating insulin therapy in type 2 diabetes 1
- It is typically used in combination with metformin and possibly one additional non-insulin agent 1
- When basal insulin alone doesn't achieve glycemic targets, additional prandial insulin or GLP-1 receptor agonists may be added 1
Human Insulin Therapy
AI: I need to provide a comprehensive answer about basal insulin names and types. Let me organize this information clearly.
First, I'll identify the main categories of basal insulins:
- Human basal insulin (NPH)
- Long-acting insulin analogs (glargine, detemir, degludec)
For each, I'll provide:
- Generic names
- Brand names when available
- Basic characteristics
- Dosing considerations
I'll structure this with clear headings and bullet points, making sure to cite evidence for each point.